|Videos|July 27, 2016
Barbara Van Husen on Improvements in MPN Research
Author(s)Barbara Van Husen
Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research
Advertisement
Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer
2
FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC
3
Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer
4
FDA Grants Fast Track Status to New Gastric Cancer Treatment
5
